BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 3466902)

  • 1. Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis.
    Gautron S; Daegelen D; Mennecier F; Dubocq D; Kahn A; Dreyfus JC
    J Clin Invest; 1987 Jan; 79(1):275-81. PubMed ID: 3466902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of functional messenger RNA for glycogen phosphorylase in the muscle of two patients with McArdle's disease.
    Daegelen D; Munnich A; Levin MJ; Girault A; Goasguen J; Kahn A; Dreyfus JC
    Ann Hum Genet; 1983 May; 47(2):107-15. PubMed ID: 6576726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular heterogeneity in McArdle's disease.
    McConchie SM; Coakley J; Edwards RH; Beynon RJ
    Biochim Biophys Acta; 1990 Nov; 1096(1):26-32. PubMed ID: 2268682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases.
    Bartram C; Edwards RH; Clague J; Beynon RJ
    Hum Mol Genet; 1993 Aug; 2(8):1291-3. PubMed ID: 8401511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. McArdle's & Hers' diseases: glycogen phosphorylase transcriptional expression in human tissues.
    Gorin FA; Mullinax RL; Ignacio PC; Neve RL; Kurnit DM
    J Neurogenet; 1987 Dec; 4(6):293-308. PubMed ID: 3509980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
    Tsujino S; Shanske S; Nonaka I; DiMauro S
    Muscle Nerve Suppl; 1995; 3():S23-7. PubMed ID: 7603523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. McArdle's disease: a rare frameshift mutation in exon 1 of the muscle glycogen phosphorylase gene.
    Bartram C; Edwards RH; Clague J; Beynon RJ
    Biochim Biophys Acta; 1994 Jul; 1226(3):341-3. PubMed ID: 8054367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myophosphorylase gene transfer in McArdle's disease myoblasts in vitro.
    Pari G; Crerar MM; Nalbantoglu J; Shoubridge E; Jani A; Tsujino S; Shanske S; DiMauro S; Howell JM; Karpati G
    Neurology; 1999 Oct; 53(6):1352-4. PubMed ID: 10522901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.
    Martinuzzi A; Vergani L; Carrozzo R; Fanin M; Bartoloni L; Angelini C; Askanas V; Engel WK
    J Clin Invest; 1993 Oct; 92(4):1774-80. PubMed ID: 8408630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. McArdle's disease: molecular genetics and metabolic consequences of the phenotype.
    Beynon RJ; Bartram C; Hopkins P; Toescu V; Gibson H; Phoenix J; Edwards RH
    Muscle Nerve Suppl; 1995; 3():S18-22. PubMed ID: 7603521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated delivery into myocytes of muscle glycogen phosphorylase, the enzyme deficient in patients with glycogen-storage disease type V.
    Baqué S; Newgard CB; Gerard RD; Guinovart JJ; Gómez-Foix AM
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):1009-14. PubMed ID: 7818463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. McArdle's disease: biochemical and molecular genetic studies.
    Servidei S; Shanske S; Zeviani M; Lebo R; Fletterick R; DiMauro S
    Ann Neurol; 1988 Dec; 24(6):774-81. PubMed ID: 3207360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. McArdle's disease--what limit to the age of onset?
    Hewlett RH; Gardner-Thorpe C
    S Afr Med J; 1978 Jan; 53(2):60-3. PubMed ID: 273990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
    Tsujino S; Shanske S; DiMauro S
    N Engl J Med; 1993 Jul; 329(4):241-5. PubMed ID: 8316268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle's syndrome to chromosome 11.
    Lebo RV; Gorin F; Fletterick RJ; Kao FT; Cheung MC; Bruce BD; Kan YW
    Science; 1984 Jul; 225(4657):57-9. PubMed ID: 6587566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. McArdle's disease-muscle glycogen phosphorylase deficiency.
    Bartram C; Edwards RH; Beynon RJ
    Biochim Biophys Acta; 1995 Aug; 1272(1):1-13. PubMed ID: 7662715
    [No Abstract]   [Full Text] [Related]  

  • 17. Peripheral nerve and vasculature involvement in myophosphorylase deficiency (McArdle's disease).
    Byard RW; Lach B; Preston DN
    Pathology; 1991 Jan; 23(1):62-5. PubMed ID: 2062570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
    Tsujino S; Shanske S; Valberg SJ; Cardinet GH; Smith BP; DiMauro S
    Neuromuscul Disord; 1996 Jan; 6(1):19-26. PubMed ID: 8845714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques.
    Daegelen-Proux D; Kahn A; Marie J; Dreyfus JC
    Ann Hum Genet; 1981 May; 45(2):113-20. PubMed ID: 6797345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low muscle levels of pyridoxine in McArdle's syndrome.
    Haller RG; Dempsey WB; Feit H; Cook JD; Knochel JP
    Am J Med; 1983 Feb; 74(2):217-20. PubMed ID: 6572033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.